Driven by a commitment to translating biotechnological innovation from the laboratory to patients, Neil has worked across the ecosystem as a scientist, founder, and investor. After completing his PhD at the University of Delaware, he founded and led Nitro Biosciences, a grant-funded vaccine company spun out of academic research. Neil also brings venture capital experience, where he has led diligence efforts for seed and Series A biotechnology companies. Together, these experiences give him a clear perspective on how to improve the efficiency and rigor of the biotech diligence process.